Natural Versus Synthetic Vitamin B Complexes in Human
Pilot Study for the Evaluation of the Effectiveness of Natural Versus Synthetic Vitamin B Complexes in Humans.
1 other identifier
interventional
30
1 country
1
Brief Summary
In a cross-over study the investigators evaluate the effects of natural (Panmol-B-Complex) (Pan \[Greek\] = all; moles \[Latin\] = molecules/particles - brand name) versus synthetic vitamin B complexes to identify the bioavailability of distinct vitamins as well as long-term effects. The primary hypothesis for this study: "Natural Vitamin B-complexes are as effective as synthetic Vitamin B-complexes or better." For this reason 30 subjects (18 to 65y; BMI \>19 to \<29) were recruited for this study. The study population was divided into 2 groups of each 15 subjects in a cross-over trial. Vitamin supplementation consisted of Thiamine (2.93 mg), Riboflavin (3.98 mg), Niacin (29.85 mg), Pantothenic acid (10.95 mg), Pyridoxine (3.38 mg), Biotin (0.108 mg), Folic acid (0.69 mg) and Cobalamin (8.85 µg) per day in both groups. Blood samples are taken at baseline - 1.5h after vitamin supplementation - 4h - 7h - 6 weeks - wash out phase I (2 weeks); start cross-over: baseline - 1.5h after vitamin supplementation - 4h - 7h - 6 weeks - washout phase II (6 weeks). In case of main target criteria Thiamin, Riboflavin, Pyridoxine, Folic acid and Cobalamin were measured in serum as well as total peroxides (µmol/L), peroxidase-activity (U/L), total antioxidant status (mmol/L) and polyphenols (mmol/L).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started May 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 3, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 17, 2017
CompletedFirst Submitted
Initial submission to the registry
January 8, 2018
CompletedFirst Posted
Study publicly available on registry
February 23, 2018
CompletedResults Posted
Study results publicly available
April 26, 2021
CompletedApril 26, 2021
April 1, 2021
5 months
January 8, 2018
February 14, 2020
April 23, 2021
Conditions
Outcome Measures
Primary Outcomes (5)
Serum Thiamine
Serum Thiamine in microgram per liter Minimum: 36 Maximum: 98
20 weeks
Serum Riboflavin
Serum Riboflavin in microgram per liter Minimum: 190 Maximum: 341
20 weeks
Serum Pyridoxine
Serum Pyridoxine in microgram per liter Minimum: 3.8 Maximum: 161.8
20 weeks
Serum Folic Acid
Serum Folic acid in nanogram per liter Minimum: 2.20 Maximum: 58.10
20 weeks
Serum Cobalamin
Serum Cobalamin in picogram per liter Minimum: 159 Maximum: 1230
20 weeks
Secondary Outcomes (5)
Serum Total Peroxides
20 weeks
Serum Total Antioxidant Capacity
20 weeks
Serum Endogenous Peroxidase-activity
20 weeks
Serum Polyphenols
20 weeks
Total Homocysteine
20 weeks
Study Arms (2)
Natural Panmol-B-Complex first, then synthetic Vitamin B-complex
ACTIVE COMPARATORParticipants first received a Natural Vitamin B-complex, i.e., Panmol-B-Complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks. After a wash-out period of 2 weeks, they then received a synthetic Vitamin B-complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks.The study finished after the second wash-out period for another 6 weeks.
Synthetic Vitamin B-complex first, then Natural Panmol-B-Complex
ACTIVE COMPARATORParticipants first received a Synthetic Vitamin B-complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks. After a wash-out period of 2 weeks, they then received a natural Vitamin B-complex, i.e., Panmol-B-complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks.The study finished after the second wash-out period for another 6 weeks.
Interventions
Natural Panmol-B-Complex: B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) - Synthetic Vitamin B-Complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg)
Synthetic Vitamin B-Complex: B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85µg) - Natural Panmol-B-Complex: B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg)
Eligibility Criteria
You may qualify if:
- Male and female
- Healthy
You may not qualify if:
- Cholesterol \>240mg/dl
- Pregnancy and lactation period
- Clinical diagnosis of chronic infections
- Ingestion of trace elements, vitamin- and fatty acid supplements in the past 3 months
- Clinical diagnosis of cardiovascular disease
- Clinical diagnosis of cancer
- Clinical diagnosis of psychotic diseases
- Insulin dependent diabetes
- Clinical diagnosis of autoimmune diseases
- Maldigestion/Malabsorption
- Veganes cuisine
- \> 1 Beer/day
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wonisch Willibald
Graz, Styria, 8036, Austria
Related Publications (2)
Lindschinger M, Tatzber F, Schimetta W, Schmid I, Lindschinger B, Cvirn G, Stanger O, Lamont E, Wonisch W. A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels. Oxid Med Cell Longev. 2019 Dec 12;2019:6082613. doi: 10.1155/2019/6082613. eCollection 2019.
PMID: 31915511RESULTLindschinger M, Tatzber F, Schimetta W, Schmid I, Lindschinger B, Cvirn G, Fuchs N, Markolin G, Lamont E, Wonisch W. [Bioavailability of natural versus synthetic B vitamins and their effects on metabolic processes]. MMW Fortschr Med. 2020 Mar;162(Suppl 4):17-27. doi: 10.1007/s15006-020-0230-4. Epub 2020 Mar 19. German.
PMID: 32189314RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Willibald Wonisch
- Organization
- Otto Loewi Research Center, Chair of Physiological Medicine, Medical University of Graz, Austria
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Masking was organized and supervised by the randomization person in charge. Group assignment was 1:1 (control vs. verum group) with identical packages for both Vitamin supplements with 126 capsules for each subject per phase. Randomization was done with sealed envelopes.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 8, 2018
First Posted
February 23, 2018
Study Start
May 8, 2017
Primary Completion
October 3, 2017
Study Completion
November 17, 2017
Last Updated
April 26, 2021
Results First Posted
April 26, 2021
Record last verified: 2021-04